Dieterle, D.; Eben, E.; Einhäupl, K.; Hippius, H.; Klein, H.; Rüther, E.; Schmauß, M. (2008). „The Effect of Fluperlapine in Acute Psychotic Patients”. Pharmacopsychiatry. 17 (2): 57—60. PMID6728910. doi:10.1055/s-2007-1017408.
nih.gov
ncbi.nlm.nih.gov
Fischer-Cornelssen, K. A. (1984). „Fluperlapine in 104 schizophrenic patients. Open multicenter trial”. Arzneimittel-Forschung. 34 (1A): 125—130. PMID6145428.
Woggon, B.; Angst, J.; Bartels, M.; Heinrich, K.; Hippius, H.; Koukkou, M.; Krebs, E.; Küfferle, B.; Müller-Oerlinghausen, B. (1984). „Antipsychotic efficacy of fluperlapine. An open multicenter trial”. Neuropsychobiology. 11 (2): 116—120. PMID6148712.
Dieterle, D.; Eben, E.; Einhäupl, K.; Hippius, H.; Klein, H.; Rüther, E.; Schmauß, M. (2008). „The Effect of Fluperlapine in Acute Psychotic Patients”. Pharmacopsychiatry. 17 (2): 57—60. PMID6728910. doi:10.1055/s-2007-1017408.
Woggon, B.; Heinrich, K.; Küfferle, B.; Müller-Oerlinghausen, B.; Pöldinger, W.; Rüther, E.; Schied, H. W. (1984). „Results of a multicenter AMDP study with fluperlapine in schizophrenic patients”. Arzneimittel-Forschung. 34 (1A): 122—124. PMID6145427.
Scholz, E.; Dichgans, J. (1985). „Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine”. European archives of psychiatry and neurological sciences. 235 (1): 60—64. PMID2864254.
Pakkenberg, H.; Pedersen, B. (1985). „Medical treatment of dystonia”. Psychopharmacology. Supplementum. 2: 111—117. ISSN0179-8456. OCLC10642795. PMID2860654.
worldcat.org
Pakkenberg, H.; Pedersen, B. (1985). „Medical treatment of dystonia”. Psychopharmacology. Supplementum. 2: 111—117. ISSN0179-8456. OCLC10642795. PMID2860654.